TPX2 silencing exerts anti ‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway.

In conclusion, TPX2 may suppress the growth of HCC by regulating the PI3K/AKT signaling pathway and thus, TPX2 may be a potential target for the treatment of liver cancer.
PMID: 31638175 [PubMed - as supplied by publisher]

Source: International Journal of Molecular Medicine - October 13, 2019 Category: Molecular Biology Authors: Huang DH, Jian J, Li S, Zhang Y, Liu LZ Tags: Int J Mol Med Source Type: research